Author

Andrés Castaño-García

CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN NATURAL HISTORY IN A WESTERN COUNTRY
CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN NATURAL HISTORY IN A WESTERN COUNTRY

Andrés Castaño-García  et al.

VARICELLA ZOSTER VIRUS ENCEPHALITIS: A POTENTIALLY SERIOUS COMPLICATION DURING TREATMENT WITH VEDOLIZUMAB
VARICELLA ZOSTER VIRUS ENCEPHALITIS: A POTENTIALLY SERIOUS COMPLICATION DURING TREATMENT WITH VEDOLIZUMAB

Andrés Castaño-García  et al.

PREVALENCE AND PATTERN OF ALCOHOL CONSUMPTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
PREVALENCE AND PATTERN OF ALCOHOL CONSUMPTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Andrés Castaño-García  et al.

SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)
SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)

Andrés Castaño-García  et al.

EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE
EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE

Andrés Castaño-García  et al.

PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU
PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU

Andrés Castaño-García  et al.

Item 1 - 6 / 6
1